Lynn Seely On Raising $1 Billion To Redefine Care For Women And Men

Lynn Seely started Myovant Sciences which delivers innovative women's health and prostate cancer solutions by efficiently advancing new medicines to market. The company has raised $1 billion from investors such as Danippon Sumitomo Pharma. Myovant Sciences was one of the largest biopharma IPOs in 2016.